autologous tumor infiltrating lymphocytes BST02
Term · Oncology and biomedicine · MLC-T-ONC-011788
A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from the patient's resected tumor and expanded ex vivo, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous TILs BST02 specifically recognize and kill the patient's tumor cells.
| Identifier | MLC-T-ONC-011788 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous TILs BST02 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011788",
"term": "autologous tumor infiltrating lymphocytes BST02",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from the patient's resected tumor and expanded ex vivo, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous TILs BST02 specifically recognize and kill the patient's tumor cells.",
"synonyms": [
"autologous TILs BST02"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-tumor-infiltrating-lymphocytes-bst02/"
}
Record 3,126 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.